Подкасты на тему Dr Neil Love

Dr David O’Malley from The Ohio State University and The James Cancer Center in Columbus, Ohio, discusses trials in ovarian cancer presented at SGO 2022. CME information and select publications here.Research To Practice

Dr Judy Garber from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent data with PARP inhibitors for breast cancer. CME information and select publications here.Research To Practice

Dr Mark Agulnik from City of Hope in Duarte, California, discusses recent therapeutic advances in soft tissue sarcoma. CME information and select publications here.Research To Practice

Dr Ajai Chari from the Tisch Cancer Institute Clinical Trials Office in New York discusses recent therapeutic advances in multiple myeloma presented at the 2021 ASH annual meeting. CME information and select publications here.Research To Practice

Dr Prithviraj Bose from The University of Texas MD Anderson Cancer Center in Houston, Texas, discusses recent therapeutic advances in myeloproliferative neoplasms presented at the 2021 ASH annual meeting. CME information and select publications here.Research To Practice

Dr Matthew Lunning from the University of Nebraska Medical Center in Omaha, Nebraska, discusses recent therapeutic advances in Hodgkin and non-Hodgkin lymphomas. CME information and select publications here.Research To Practice

Dr Andrew Brunner from the Massachusetts General Hospital Cancer Center in Boston, Massachusetts, discusses updates from ASH 2021 on the management of acute myeloid leukemia and myelodysplastic syndromes. CME information and select publications here.Research To Practice

Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses current issues in the research and management of localized estrogen receptor-positive breast cancer. CME information and select publications here.Research To Practice

Dr Peter Hillmen from the University of Leeds in Leeds, England, discusses recent advances in the management of chronic lymphocytic leukemia. CME information and select publications here.Research To Practice

Dr Matthew Davids from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent therapeutic advances in chronic lymphocytic leukemia presented at ASH 2021. CME information and select publications here.Research To Practice

Dr Saad Zafar Usmani from the Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent therapeutic advances in transplant-ineligible newly diagnosed multiple myeloma. CME information and select publications here.Research To Practice

Dr Evan Yu from the Fred Hutchinson Cancer Research Center in Seattle, Washington, discusses recent therapeutic advances in metastatic castration-resistant prostate cancer CME information and select publications here.Research To Practice

Dr Christopher Lieu from the University of Colorado Cancer Center in Aurora, Colorado, discusses recent therapeutic advances in the management of colorectal cancers. CME information and select publications here.Research To Practice

Dr Michael Pishvaian from the Johns Hopkins University School of Medicine in Washington, DC, discusses recent therapeutic advances in pancreatic cancer. CME information and select publications here.Research To Practice

Dr Alan Bryce from the Mayo Clinic in Phoenix, Arizona, discusses current practice patterns and recent advances in the management of metastatic castration-resistant prostate cancer. CME information and select publications here.Research To Practice

Dr Arvind Dasari from the University of Texas MD Anderson Cancer Center discusses recent advances and future directions for the management of early-stage and advanced colorectal cancers. CME information and select publications here.Research To Practice

Dr Bradley Monk from the University of Arizona College of Medicine in Phoenix discusses the management of advanced ovarian cancers. CME information and select publications here.Research To Practice

Dr Gregory Riely from the Memorial Sloan Kettering Cancer Center in New York City discusses recent advances and future directions in the management of patients with NSCLC and EGFR exon 20 insertion mutations. CME information and select publications here.Research To Practice

Dr Adil Daud from the UCSF Helen Diller Family Comprehensive Cancer Center discusses recent advances and future directions in the use of immunotherapy for the management of wild-type and BRAF-mutant melanoma. CME information and select publications here.Research To Practice

Dr Andrew Evens from the Rutgers Cancer Institute in New Jersey discusses the management of newly diagnosed and advanced Hodgkin lymphoma in younger and older patients. CME information and select publications here.Research To Practice

Dr Matthew Powell from the Washington University School of Medicine in St Louis, Missouri, discusses therapeutic advances and novel investigational strategies for the management of endometrial cancer. CME information and select publications here.Research To Practice

Dr Arnon Kater from the Amsterdam University Medical Centers in Amsterdam discusses recent advances in the management of chronic lymphocytic leukemia. CME information and select publications here.Research To Practice

Dr Michael Savona from Vanderbilt University School of Medicine in Nashville, Tennessee, discusses recent advances and future directions in the management of myelodysplastic syndromes. CME information and select publications here.Research To Practice

Dr Jonathon Cohen from the Winship Cancer Institute of Emory University in Atlanta discusses recent advances and future directions in the use of CAR T-cell therapy for the management of non-Hodgkin lymphoma. CME information and select publications here.Research To Practice

Dr Cristina Rodriguez from the Fred Hutchinson Cancer Research Center in Seattle discusses the current management of head and neck cancers. CME information and select publications here.Research To Practice

Dr Ruben Mesa from the Mays Cancer Center in San Antonio, Texas, discusses the pathogenesis and management of myeloproliferative neoplasms. CME information and select publications here.Research To Practice

Dr Michael Mauro from the Memorial Sloan Kettering Cancer Center in New York City, New York, discusses the management of chronic myeloid leukemia. CME information and select publications here.Research To Practice

Dr Sumanta Pal from the City of Hope Comprehensive Cancer Center in Duarte, California discusses the management of advanced renal cell carcinoma. CME information and select publications here.Research To Practice

Dr Marcia Brose from the Sidney Kimmel Cancer Center in Philadelphia discusses the latest clinical data on targeted therapeutic approaches for the management of advanced thyroid cancer. CME information and select publications here.Research To Practice

Dr Samuel Klempner from Massachusetts General Hospital in Boston, Massachusetts discusses recent updates on immunotherapy and targeted therapy for gastroesophageal cancers. CME information and select publications here.Research To Practice

Dr Ian Krop from the Dana-Farber Cancer Institute in Boston discusses recently published and emerging research on the treatment of HER2-low breast cancer. CME information and select publications here.Research To Practice

Dr Kathleen Moore from the University of Oklahoma Health Sciences Center in Oklahoma City, Oklahoma, discusses key presentations on gynecologic cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice

Dr Lori Wirth from the Massachusetts General Hospital in Boston discusses the latest clinical data and ongoing investigations on targeted therapeutic approaches for the management of RET-altered and NTRK fusion-positive thyroid cancers. CME information and select publications here.Research To Practice

Dr Joel Neal from Stanford University in Stanford, California, discusses key presentations on lung cancer from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice

Dr Jesús Berdeja from the Sarah Cannon Research Institute in Nashville, Tennessee, discusses recent advances and future directions in the use of CAR T-cell therapy for the management of multiple myeloma. CME information and select publications here.Research To Practice

Dr Kristen Ciombor from the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, discusses key presentations on gastrointestinal cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice

Dr Sara Tolaney from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses key presentations on breast cancer from the 2021 ASCO Annual meeting. CME information and select publications here.Research To Practice

Dr Jaffer Ajani from MD Anderson Cancer Center in Houston, Texas discusses the latest clinical data on immune checkpoint inhibitors and other novel agents in the management of gastroesophageal cancers. CME information and select publications here.Research To Practice

Dr Arjun Balar from the NYU Perlmutter Cancer Center in New York discusses key presentations on genitourinary cancers from the 2021 ASCO Annual Meeting. CME information and select publications here.Research To Practice

Dr Guillermo Garcia-Manero from the MD Anderson Cancer Center discusses clinical data with new and emerging approaches for the management of myelodysplastic syndromes. CME information and select publications here.Research To Practice

Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer. CME information and select publications here.Research To Practice

Dr Kevin Kalinsky from Emory University in Atlanta discusses the role of genomic assays in treatment decision-making for patients with hormone receptor-positive, HER2-negative, early-stage breast cancer. CME information and select publications here.Research To Practice

Dr Morie Gertz from the Mayo Clinic in Rochester, Minnesota, discusses the diagnosis and management of amyloid light chain amyloidosis. CME information and select publications here.Research To Practice

Mitesh Borad from the Mayo Clinic Comprehensive Cancer Center in Scottsdale, Arizona, discusses the biology of cholangiocarcinoma and clinical data with new and emerging targeted approaches for patients with this disease. CME information and select publications here.Research To Practice

Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation. CME information and select publications here.Research To Practice

Dr Laurie Sehn from the BC Cancer Center for Lymphoid Cancer in Vancouver, Canada, discusses the latest clinical research findings on non-Hodgkin and Hodgkin lymphomas from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice

Dr Natalie Callander from the University of Wisconsin Carbone Cancer Center discusses key presentations on multiple myeloma, Waldenström macroglobulinemia and amyloidosis from the 2020 ASH Annual Meeting. CME information and select publications here.Research To Practice

Dr Roberto Iacovelli from the Fondazione Policlinico Universitario A Gemelli in Rome discusses the spectrum and management of side effects with hormonal therapies in prostate cancer. CME information and select publications here.Research To Practice

Dr Harry Erba from Duke University in Durham, North Carolina, discusses key presentations on acute myeloid leukemia and myelodysplastic syndromes from the 2020 AS Annual Meeting. CME information and select publications here.Research To Practice

Dr Manmeet Ahluwalia from the Miami Cancer Institute of Baptist Health South Florida discusses recently published and emerging research on the management of CNS metastases in patients with non-small cell lung cancer. CME information and select publications here.Research To Practice